NCT07439848: Mesenchymal Stem Cells (MSCs) and Conditioned Medium Mesenchymal Stem Cells as Adjuvant Therapy for Sepsis
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 15 planned
- Started
- 25 Dec 2023
- Primary completion
- Dec 2026
- Arms
- Umbilical Cord Mesenchymal Stem Cell (UC-MSC)
- Results
- None posted
- 25 Dec 2023: Trial started
- 27 Feb 2026: Trial registered